In neonatal NPC1 patients, cholestatic jaundice and liver dysfunction occur frequently; while some neonatal patients exhibit transient hepatosplenomegaly that resolves by 4 months of age, up to 10% of others exhibit rapidly progressing liver dysfunction that is fatal1,17. Here, NPC1 is linked to Decreased liver function.